Javier Vázquez-Bourgon

Has grant

Assistant Professor of Psychiatry

Universidad de Cantabria

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Javier Vázquez-Bourgon is an Assistant Professor of Psychiatry at the University of Cantabria, Spain. His research areas include the longitudinal assessment of psychosis, the impact of metabolic syndrome in first-episode psychosis, and the effects of antipsychotic treatments. He has published extensively on topics such as cognitive profiles in psychosis and the mental health impact of COVID-19 among healthcare workers.

Recent Grants

Grant: Close

The role of dopaMINE in bRain-liVer Axis in psychosis patients developing non-alcoholic fatty lIver diseae. The MINERVA study.

Open Date: 2021-01-01

Close Date: 2023-01-01

Grant: Close

Tratamiento estratificado en esquizofrenia: Integrando resultados de transcriptoma humano y celular en las estrategias de Tratamiento antipsicótico.

Open Date: 2019-04-01

Close Date: 2021-06-01

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (15)

Antonio Pardiñas

Lecturer

Cardiff University

UNITED KINGDOM

Javier Vázquez-Bourgon

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

Cross-sectional and longitudinal assessment of the association between DDR1 variants and processing speed in patients with early psychosis and healthy controls

Longitudinal trajectories in negative symptoms and changes in brain cortical thickness: 10-year follow-up study

Intelligence quotient changes over 10 years: Diversity of cognitive profiles in first episode of psychosis and healthy controls.

Polygenic risk scores enhance prediction of body mass index increase in individuals with a first episode of psychosis.

Long-term mental health impact of COVID-19 on Primary Care health workers in northern Spain; results from a two-phase longitudinal study.

Metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: 3 years follow-up results from the PAFIP cohort

Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosis

Obesity and brain structure in schizophrenia - ENIGMA study in 3021 individuals.

Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial

Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis

Naturalistic study on the use of clozapine in the early phases of non-affective psychosis: A 10-year follow-up study in the PAFIP-10 cohort

Collaborators (15)

Antonio Pardiñas

Antonin Skoch

Gary Donohoe

Karl David Neergaard

James MacCabe

Jorge Moya-Higueras

Udo Dannlowski

Sean R. McWhinney

Lourdes Martorell

Thomas Weickert

vanessa sanchez-gistau

Sophie Smart

Nancy Murillo-García

Benedicto Crespo-Facorro

paolo brambilla

Make your next move.